ABCA7 and Cognitive impairment: Accumulating evidence through genetic studies suggests that the contribution of ABCA7 to AD risk is mediated by the dysfunction of ABCA7 expression (Aikawa et al., 2018), such that, increased ABCA7 expression levels have been associated with more severe cognitive deficits in AD subjects (Karch et al., 2012).